南财智讯4月23日电，泰德医药（03880.HK）公告，截至2025年12月31日止年度，公司总收入为人民币5.70亿元，同比增长28.9%；年内溢利为人民币2.17亿元，同比增长267.3%；每股基本盈利为人民币1.53元。 （文章来源：南方财经网）
Source Link南财智讯4月23日电，泰德医药（03880.HK）公告，截至2025年12月31日止年度，公司总收入为人民币5.70亿元，同比增长28.9%；年内溢利为人民币2.17亿元，同比增长267.3%；每股基本盈利为人民币1.53元。 （文章来源：南方财经网）
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.